BIO logo

BIO
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

1,000
Mkt Cap
$7.46B
Volume
436,678.00
52W High
$343.12
52W Low
$211.43
PE Ratio
9.91
BIO Fundamentals
Price
$276.53
Prev Close
$273.60
Open
$272.48
50D MA
$283.76
Beta
0.88
Avg. Volume
321,003.35
EPS (Annual)
$27.85
P/B
1.00
Rev/Employee
$346,738.26
$8,108.47
Loading...
Loading...
News
all
press releases
Moore Capital Management LP Acquires Shares of 55,000 Bio-Rad Laboratories, Inc. $BIO
Moore Capital Management LP bought a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the third quarter, according to the company in its most recent filing with the...
MarketBeat·10d ago
News Placeholder
More News
News Placeholder
Gotham Asset Management LLC Acquires 36,763 Shares of Bio-Rad Laboratories, Inc. $BIO
Gotham Asset Management LLC boosted its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 41.8% during the 3rd quarter, according to its most recent disclosure with the Securities...
MarketBeat·10d ago
News Placeholder
Hound Partners LLC Has $29.15 Million Stake in Bio-Rad Laboratories, Inc. $BIO
Hound Partners LLC decreased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 42.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The...
MarketBeat·11d ago
News Placeholder
Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Rating of "Hold" by Brokerages
Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) has been given a consensus rating of "Hold" by the six research firms that are covering the stock, Marketbeat Ratings reports. One research...
MarketBeat·11d ago
News Placeholder
Mangrove Partners IM LLC Invests $35.57 Million in Bio-Rad Laboratories, Inc. $BIO
Mangrove Partners IM LLC acquired a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the third quarter, according to its most recent 13F filing with the Securities...
MarketBeat·13d ago
News Placeholder
Perbak Capital Partners LLP Purchases 5,423 Shares of Bio-Rad Laboratories, Inc. $BIO
Perbak Capital Partners LLP grew its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 171.7% in the third quarter, according to the company in its most recent 13F filing...
MarketBeat·13d ago
News Placeholder
Portolan Capital Management LLC Has $13.02 Million Stock Position in Bio-Rad Laboratories, Inc. $BIO
Portolan Capital Management LLC reduced its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 26.0% during the 3rd quarter, according to the company in its most recent disclosure...
MarketBeat·13d ago
News Placeholder
10,425 Shares in Bio-Rad Laboratories, Inc. $BIO Purchased by Magnetar Financial LLC
Magnetar Financial LLC acquired a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC...
MarketBeat·15d ago
News Placeholder
Bio-Rad Laboratories, Inc. $BIO Shares Purchased by Natixis Advisors LLC
Natixis Advisors LLC grew its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 67.1% during the 3rd quarter, according to the company in its most recent filing with the...
MarketBeat·15d ago
News Placeholder
Capital Research Global Investors Makes New Investment in Bio-Rad Laboratories, Inc. $BIO
Capital Research Global Investors bought a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the third quarter, according to the company in its most recent filing...
MarketBeat·15d ago
<
1
2
...
>

Latest BIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.